Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, April 18, 2012
BioClinica®, Inc., (NASDAQ: BIOC), a global provider of clinical trial management solutions, today announced that members of its team will attend, participate in and speak at several upcoming industry conferences in April, May, and June. BioClinica ...
read more
BioClinica®, Inc., a global provider of clinical trial management solutions, announced today the introduction of StudyView™, a clinical trials portal and reporting hub that dramatically increases clinical trials operational visibility. StudyView ...
read more
BioClinica®, Inc., a global provider of clinical trial management services, has recently announced several major initiatives to better serve its growing sponsor client base in China and other Asia Pacific countries, following its March 2013 merger ...
read more
BioClinica, Inc., a global provider of clinical trial management services, announced today that JLL Partners and Ampersand Capital Partners, two leading middle market private equity firms, have completed their acquisition of BioClinica and CoreLab ...
read more
BioClinica®, Inc., a global provider of clinical trial management solutions, announced that it is, together with C.R. Bard, a 2012 winner of Microsoft Corporation’s prestigious Life Sciences Innovation Award. The awards, announced at the Drug ...
read more
BioClinica®, Inc., a leading provider of eClinical Solutions for the Pharmaceutical Industry, has announced the acquisition of Blueprint Clinical, a fast-growing company offering ground-breaking technology and extensive expertise to drive successful ...
read more
BioAgilytix Labs, LLC, a global contract research laboratory focused on supporting its pharmaceutical and biotech partners in all stages of large molecule drug development, announced that it signed a definitive agreement to purchase 360biolabs®, the ...
read more
Ben Venue Laboratories. Inc. (“Ben Venue”), a member of the Boehringer Ingelheim Group of Companies, announced today that the company has signed an asset purchase agreement for the sale of the assets of Bedford Laboratories, Ben Venue’s U.S. ...
read more
Thursday, September 24, 2020
Beechtree Labs has chosen Curavit Clinical Research for a fully decentralized clinical trial to investigate a Covid-19 therapy.
read more
Tuesday, January 17, 2023
Be The Match BioTherapies® announced it is offering CIBMTR® (Center for International Blood and Marrow Transplant Research) Clinical Research Organization Services (CRO Services), which allows sponsors to significantly reduce the time required to ...
read more
Tuesday, September 24, 2019
Bayer, Brigham and Women's Hospital, and Massachusetts General Hospital announced the launch of a joint lab to research new drug candidates to treat chronic lung diseases.
read more
Monday, November 06, 2017
The new study will focus on high-risk older adults to determine whether an investigational drug can prevent or delay the emergence of symptoms by combatting the accumulation of amyloid plaques.
read more
Veeva Systems announced that B. Braun SE (B. Braun), one of the world's leading manufacturers of medical technology and pharmaceutical products, has selected Veeva Vault Clinical Operations Suite to modernize study management and payments to partner ...
read more
Tuesday, January 17, 2023
Avacta Group, a life sciences company developing innovative, targeted oncology drugs and powerful diagnostics announces that AVA6000 continues to show a very favourable safety profile in the fourth dose cohort of the ALS-6000-101 dose escalation ...
read more
Wednesday, November 19, 2014
Auxiliis, a full-service contract research organisation (CRO) dedicated exclusively to paediatric clinical trials, has raised EUR 1.3 million from Alliance Jura Hongrie, a Budapest-based venture capital fund.
read more